Skip to content

Lung Cancer Blog

Everything about lung cancer is here.

Menu
  • Home
  • About Us
  • Lung Cancer
    • Lung Cancer News
    • Causes of Lung Cancer
    • Lung Cancer Symptoms
    • Types of Lung Cancer
    • Stages of Lung Cancer
    • Lung Cancer Treatment
    • Lung Cancer Drugs
    • Lung Cancer In Ayurveda
    • Chinese Herbs For Lung Cancer
  • Researches
  • Studies
  • Stories
  • Sitemap
  • Contact Us
Menu
Lung Cancer

New Study Identifies Drug to Boost Lung Cancer Survival Rates

Posted on October 5, 2020
Post Views: 692

A new study has found that a newly approved drug for leading form of cancer, lung cancer works to improve patient survival rate. The immunotherapy drug is called Tecentriq or atezolizumab. It was approved earlier by US Food and Drug Administration to treat newly diagnosed non-small cell lung cancer (NSCLC). NSCLC comprises up to 85% of all lung cancers. Tecentriq works by targeting a protein called PD-L1 that lies on the surface of tumor cells.

As PD-L1 signals body’s immune system T cells not to attack and thus, by targeting it; Tecentriq unleashes body’s natural T cells to target and destroy the cancer cells. The researchers also explained that Tecentriq has already shown excellent progress in chemotherapy patients and this study confirmed that the drug is active in selected patients who have not received any lung cancer treatment.

In this study, 554 patients with stage 4 metastatic NSCLC tumors were included. They had tumors lacking mutations in EGFR or ALK genes. Among 205 patients who have tumors with high cellular expression of PD-L1, the median overall survival was 20 months for those who received Tecentriq as compared to 13 months for those who received standard platinum-based chemotherapy. Median progression-free survival was eight months for patients who received Tecentriq in comparison to five months for those on standard chemotherapy.

Study lead author Dr. Roy Herbst said, “These are exciting results that could be life-changing for many patients.” Dr. Herbst is the chief of medical oncology at the Yale Cancer Center and the Smilow Cancer Hospital. The results of the study were published in the New England Journal of Medicine.

The information shared in this blog is for educational purposes only.

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • Click to share on Pinterest (Opens in new window) Pinterest
  • Click to share on Threads (Opens in new window) Threads
  • Click to share on WhatsApp (Opens in new window) WhatsApp
  • Click to share on Reddit (Opens in new window) Reddit
  • Click to share on Tumblr (Opens in new window) Tumblr
  • Click to share on Pocket (Opens in new window) Pocket
  • Click to share on Telegram (Opens in new window) Telegram

Like this:

Like Loading...

Subscribe Us

Popular Articles

  • Lung Cancer Treatment in Ayurveda (7,303)
  • Lung Cancer: Symptoms and Treatment (5,625)
  • What is Non-Small-Cell Lung Cancer? (5,531)

Recent Comments

  • Lung Cancer on New Study To Help Advance Research In Lung Cancer
  • Laurie B Grimes on New Study To Help Advance Research In Lung Cancer
  • Lung Cancer on Asbestos and Lung Cancer – What’s The Link?

Recent Articles

  • FDA Grants Accelerated Approval to Telisotuzumab Vedotin-tllv for NSCLC May 19, 2025
  • Heart-Sparing Technique in Lung Cancer Radiotherapy May 12, 2025
  • Origins of Common Lung Cancer Linked to Smoking Discovered May 5, 2025
  • Lung Cancer Screening Is Beneficial For Non-Smokers As Well April 28, 2025
  • Understanding The Stage 0 Lung Cancer April 21, 2025

Lung Cancer Blog

Lung Cancer Blog provides all lung cancer related information for educational purposes.

Disclaimer

Some post may contain affiliate links, purchasing that product not going to cost extra but by your purchase Lung Cancer will get some little commission and that amount will help in surviving this website. So, please don’t hesitate to buy from these affiliate links.

Contact Us

If you have any query or suggestions about our blog, please feel free to email us at  lungcancersymptomsx@gmail.com.

Copyright © 2012 - 2025 Lung Cancer Blog. Wordpress by Vipasha. Privacy Policy
%d